UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 108

Sortiert nach

Pembrolizumab versus docetaxel for previously treated, PD-L1-positive, advanced non-small-cell lung cancer (KEYNOTE-010): a randomised controlled trial

The Lancet (British edition), 2016-04, Vol.387 (10027), p.1540-1550

2016

Link zum Volltext

Verfügbarkeit prüfen

Congophilic Fibrillary Glomerulonephritis: A Case Series

American journal of kidney diseases, 2018-09, Vol.72 (3), p.325-336

2018

Link zum Volltext

Verfügbarkeit prüfen

Biopsy-Proven Acute Interstitial Nephritis, 1993-2011: A Case Series

American journal of kidney diseases, 2014-10, Vol.64 (4), p.558-566

2014

Link zum Volltext

Verfügbarkeit prüfen

Kidney Biopsy Findings in Patients With COVID-19, Kidney Injury, and Proteinuria

American journal of kidney diseases, 2021-03, Vol.77 (3), p.465-468

2021

Link zum Volltext

Verfügbarkeit prüfen

Clinicopathologic Correlations in Multiple Myeloma: A Case Series of 190 Patients With Kidney Biopsies

American journal of kidney diseases, 2012-06, Vol.59 (6), p.786-794

2012

Link zum Volltext

Verfügbarkeit prüfen

Immunoglobulin-Negative DNAJB9-Associated Fibrillary Glomerulonephritis: A Report of 9 Cases

American journal of kidney diseases, 2021-03, Vol.77 (3), p.454-458

2021

Link zum Volltext

Verfügbarkeit prüfen

The Potential Predictive Value of Cyclooxygenase-2 Expression and Increased Risk of Gastrointestinal Hemorrhage in Advanced Non–Small Cell Lung Cancer Patients Treated with Erlotinib and Celecoxib

Clinical cancer research, 2008-04, Vol.14 (7), p.2088-2094

2008

Link zum Volltext

Verfügbarkeit prüfen

Randomized, double-blind, placebo-controlled, multicenter phase II study of the efficacy and safety of apricoxib in combination with either docetaxel or pemetrexed in patients with biomarker-selected non-small-cell lung cancer

Journal of clinical oncology, 2015-01, Vol.33 (2), p.189-194

2015

Link zum Volltext

Verfügbarkeit prüfen

Acquired glomerular lesions in patients with Down syndrome

Human pathology, 2012, Vol.43 (1), p.81-88

2012

Link zum Volltext

Verfügbarkeit prüfen

Utility of Insulin-like Growth Factor Receptor-1 Expression in Gefitinib-Treated Patients with Non-small Cell Lung Cancer

Anticancer research, 2012-05, Vol.32 (5), p.1705-1710

2012

Link zum Volltext

Verfügbarkeit prüfen

Mitochondrial cerebellar ataxia, renal failure, neuropathy, and encephalopathy (MCARNE)

Neurology. Genetics, 2019-04, Vol.5 (2), p.e314-e314

2019

Link zum Volltext

Verfügbarkeit prüfen

M itochondrial c erebellar a taxia, r enal failure, n europathy, and e ncephalopathy (MCARNE)

Neurology. Genetics, 2019-04, Vol.5 (2), p.e314

2019

Link zum Volltext

Verfügbarkeit prüfen

Osimertinib in Resected EGFR-Mutated Non–Small-Cell Lung Cancer

The New England journal of medicine, 2020-10, Vol.383 (18), p.1711-1723

2020

Link zum Volltext

Verfügbarkeit prüfen

Pembrolizumab versus methotrexate, docetaxel, or cetuximab for recurrent or metastatic head-and-neck squamous cell carcinoma (KEYNOTE-040): a randomised, open-label, phase 3 study

The Lancet (British edition), 2019-01, Vol.393 (10167), p.156-167

2019

Link zum Volltext

Verfügbarkeit prüfen

RNA sequencing to characterize pathways in EGFR-mutated non-small cell lung cancer

Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.e21019-e21019

2023

Link zum Volltext

Verfügbarkeit prüfen

Clinical outcomes in patients with radioiodine refractory thyroid carcinoma treated with dose-reduced lenvatinib

Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.e18104-e18104

2023

Link zum Volltext

Verfügbarkeit prüfen

Relationship between level of PD-L1 expression and outcomes in the KEYNOTE-010 study of pembrolizumab vs docetaxel for previously treated, PD-L1–Positive NSCLC

Journal of clinical oncology, 2016-05, Vol.34 (15_suppl), p.9015-9015

2016

Link zum Volltext

Verfügbarkeit prüfen

Gender and weight change, skeletal muscle index(SMI) change, and survival in advanced non-small cell lung cancer(NSCLC) patients(pts.) receiving platinum chemotherapy

Journal of clinical oncology, 2022-06, Vol.40 (16_suppl), p.e24080-e24080

2022

Link zum Volltext

Verfügbarkeit prüfen

Clinical and laboratory parameters associated with rapid progression in advanced NSCLC patients treated with second or third-line single agent immune checkpoint inhibitors (ICIs)

Journal of clinical oncology, 2022-06, Vol.40 (16_suppl), p.e21087-e21087

2022

Link zum Volltext

Verfügbarkeit prüfen

Perioperative Durvalumab for Resectable Non–Small-Cell Lung Cancer

The New England journal of medicine, 2023-11, Vol.389 (18), p.1672-1684

2023

Link zum Volltext

Verfügbarkeit prüfen

Abstract 1621: Comprehensive profiling of immune regulatory molecules in baseline sera from advanced stage NSCLC patients receiving anti-PD-1 and anti-PD-L1 immunotherapy: A prognostic potential

Cancer research (Chicago, Ill.), 2021-07, Vol.81 (13_Supplement), p.1621-1621

2021

Link zum Volltext

Verfügbarkeit prüfen

Intratumoral injection of the seasonal flu shot converts immunologically cold tumors to hot and serves as an immunotherapy for cancer

Proceedings of the National Academy of Sciences - PNAS, 2020-01, Vol.117 (2), p.1119-1128

2020

Link zum Volltext

Verfügbarkeit prüfen

Blood-based biomarker analysis in high PD-L1 expressing NSCLC treated with PD-1/PD-L1 based therapy with or without the addition of platinum-based chemotherapy

Journal of clinical oncology, 2021-05, Vol.39 (15_suppl), p.TPS9126-TPS9126

2021

Link zum Volltext

Verfügbarkeit prüfen

Associations between longitudinal pretreatment BMI and neutrophil/lymphocyte ratio(NLR) and progression-free(PFS) and overall survival(OS) in advanced NSCLC patients treated with single agent anti-PD-1/anti-PDL1 monoclonal antibodies(mAbs)

Journal of clinical oncology, 2021-05, Vol.39 (15_suppl), p.e21189-e21189

2021

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 108

Suche als RSS-Feed

Aktive Filter

KollektionWiley Online Library Full Collection 2018

KollektionNUS Single-Journal Subscriptions

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(107)
Mit Volltextzugriff
(104)

Publikationsform

Artikel
(108)

Sprache

Englisch
(108)
Japanisch
(5)

Erscheinungsjahr

n.n

Thema

Science & Technology
(32)
Life Sciences & Biomedicine
(31)
Humans
(30)
Female
(23)
Male
(22)
Middle Aged
(15)
Adult
(11)
Aged
(11)
Lung Neoplasms - Drug Therapy
(10)
Oncology
(10)
Carcinoma, Non-Small-Cell Lung - Drug Therapy
(9)
Lung Cancer
(9)
Biological And Medical Sciences
(8)
Chemotherapy
(8)
Medical Sciences
(8)
Treatment Outcome
(7)
Tumors
(7)
Urology & Nephrology
(7)
Antineoplastic Agents - Therapeutic Use
(6)
General & Internal Medicine
(6)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Pembrolizumab versus docetaxel for previously treated, PD-L1-positive, advanced non-small-cell lung cancer (KEYNOTE-010): a randomised controlled trial

Congophilic Fibrillary Glomerulonephritis: A Case Series

Biopsy-Proven Acute Interstitial Nephritis, 1993-2011: A Case Series

Kidney Biopsy Findings in Patients With COVID-19, Kidney Injury, and Proteinuria

Clinicopathologic Correlations in Multiple Myeloma: A Case Series of 190 Patients With Kidney Biopsies

Immunoglobulin-Negative DNAJB9-Associated Fibrillary Glomerulonephritis: A Report of 9 Cases

Praluzatamab Ravtansine, a CD166-Targeting Antibody-Drug Conjugate, in Patients with Advanced Solid Tumors: An Open-Label Phase I/II Trial

The Potential Predictive Value of Cyclooxygenase-2 Expression and Increased Risk of Gastrointestinal Hemorrhage in Advanced Non–Small Cell Lung Cancer Patients Treated with Erlotinib and Celecoxib

Randomized, double-blind, placebo-controlled, multicenter phase II study of the efficacy and safety of apricoxib in combination with either docetaxel or pemetrexed in patients with biomarker-selected non-small-cell lung cancer

Acquired glomerular lesions in patients with Down syndrome

Utility of Insulin-like Growth Factor Receptor-1 Expression in Gefitinib-Treated Patients with Non-small Cell Lung Cancer

Mitochondrial cerebellar ataxia, renal failure, neuropathy, and encephalopathy (MCARNE)

M itochondrial c erebellar a taxia, r enal failure, n europathy, and e ncephalopathy (MCARNE)

Osimertinib in Resected EGFR-Mutated Non–Small-Cell Lung Cancer

Pembrolizumab versus methotrexate, docetaxel, or cetuximab for recurrent or metastatic head-and-neck squamous cell carcinoma (KEYNOTE-040): a randomised, open-label, phase 3 study

RNA sequencing to characterize pathways in EGFR-mutated non-small cell lung cancer

Clinical outcomes in patients with radioiodine refractory thyroid carcinoma treated with dose-reduced lenvatinib

Relationship between level of PD-L1 expression and outcomes in the KEYNOTE-010 study of pembrolizumab vs docetaxel for previously treated, PD-L1–Positive NSCLC

Gender and weight change, skeletal muscle index(SMI) change, and survival in advanced non-small cell lung cancer(NSCLC) patients(pts.) receiving platinum chemotherapy

Clinical and laboratory parameters associated with rapid progression in advanced NSCLC patients treated with second or third-line single agent immune checkpoint inhibitors (ICIs)

Perioperative Durvalumab for Resectable Non–Small-Cell Lung Cancer

Abstract 1621: Comprehensive profiling of immune regulatory molecules in baseline sera from advanced stage NSCLC patients receiving anti-PD-1 and anti-PD-L1 immunotherapy: A prognostic potential

Intratumoral injection of the seasonal flu shot converts immunologically cold tumors to hot and serves as an immunotherapy for cancer

Blood-based biomarker analysis in high PD-L1 expressing NSCLC treated with PD-1/PD-L1 based therapy with or without the addition of platinum-based chemotherapy

Associations between longitudinal pretreatment BMI and neutrophil/lymphocyte ratio(NLR) and progression-free(PFS) and overall survival(OS) in advanced NSCLC patients treated with single agent anti-PD-1/anti-PDL1 monoclonal antibodies(mAbs)

Aktive Filter

Suchergebnisse filtern